Skip to content
Bentley logo — Development & manufacture of innovative endovascular product...

Bentley

Development & manufacture of innovative endovascular products for the treatment of peripheral vascular & aortic disease.

Founded 2009 Germany Hechingen, Germany 353 employees Manufacturing

General Information

Company Name Bentley
Founded Year 2009
Location Germany Hechingen, Germany
Employees 353
Industries Manufacturing
Business Model B2B, B2B2B
Revenue Model Product Sales, One Time Purchase, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with Bentley. To contact Bentley, visit bentley.global.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Bentley compare?

A PDF of Bentley and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Bentley soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Bentley

Bentley is a dynamic player in the manufacturing industry, specializing in the development and manufacture of innovative endovascular products aimed at treating peripheral vascular and aortic diseases. Established in 2009, the company has built a strong reputation under the leadership of medical entrepreneurs Lars Sunnanväder and Miko Obradovic.

Headquartered in Germany, Bentley has achieved substantial growth since the launch of its first product in 2012. Its robust portfolio includes ten top-line products, notable for their market presence in over 80 countries. Most prominently, Bentley claims a unique market position by offering the only covered balloon expandable stent available worldwide for sizes ranging from 2.5 mm to 30 mm.

The company recently received an investment backed by AP Moller Holding, Keensight Capital, and Bonit Capital as of 01 October 2023. This underscores Bentley's high growth potential and makes it an attractive option for venture capitalists and investors seeking opportunities in the innovative medical manufacturing space.

Business keywords: Endovascular Products, Peripheral Vascular Disease, Aortic Disease Treatment, Vascular Implants, Minimal-invasive Treatments, Cardiac Stents, Balloon Expandable Stent, Interventional Cardiology, Vascular Surgery, Interventional Radiology, Stent Grafts, Aneurysm Management, Stenosis Treatment, Covered Stents, Crossing Catheters

Services & Products

development of implants and catheters
manufacturing of endovascular devices
market access and distribution of medical products
collaborations in clinical studies for vascular procedures

Target Customers

healthcare professionals vascular surgeons hospitals and medical institutions endovascular specialists

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Round Undisclosed 3
AP Moller Holding, Keensight Capital +1
01 Oct 2023

Bentley Alternatives & Competitors

View All Alternatives
Bentley vs

The patient always comes first

Venture round
29 employees
Health Care, Manufacturing
Bentley vs

Pioneering advanced cardiovascular medical devices for life-saving heart treatments.

Private Equity
201-500 employees
Health Care, Manufacturing
Bentley vs
Intact Vascular
Intact Vascular United States

Founded in 2011, Intact Vascular located in Wayne, PA is a privately held medical device company tha...

Debt Financing
6 employees
Health Care, Manufacturing

FAQ About Bentley

Development & manufacture of innovative endovascular products for the treatment of peripheral vascular & aortic disease.
Bentley was founded in 2009.
Bentley is headquartered in Hechingen, Germany.
Bentley operates in Manufacturing. Its work centres on Endovascular Products, Peripheral Vascular Disease, Aortic Disease Treatment and Vascular Implants. Its customers include healthcare professionals, vascular surgeons and hospitals and medical institutions.
Bentley has a B2B and B2B2B business model. Its revenue comes from Product Sales, One Time Purchase and Tiered Pricing.
Bentley has approximately 353 employees.
Bentley has completed 1 funding round.
Bentley offers: development of implants and catheters, manufacturing of endovascular devices, market access and distribution of medical products, collaborations in clinical studies for vascular procedures.
Top alternatives and competitors to Bentley include MicroPort Endovastec, Relisys, Intact Vascular, Relisys Medical Devices Limited, Occlutech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bentley and MicroPort Endovastec are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bentley, https://www.bouncewatch.com/company/bentley, updated 26 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout